Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFR.L Regulatory News (AFR)

  • There is currently no data for AFR

Form 8.5 (EPT/RI) - Afren Plc

2 Jan 2015 10:08

RNS Number : 1499B
Morgan Stanley & Co. Int'l plc
02 January 2015
Β 

Β 

Β FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

Morgan Stanley & Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Afren Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Β 

Afren Plc

(d) Date dealing undertaken:

31 DECEMBER 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

(a) Purchases and sales

Β 

Β Class of relevant security

Β Purchases/sales

Β Total number of securities

Β Highest price per unit paid/received

Β Lowest price per unit paid/received

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A Β 

Β 

Β 

(b) Derivatives transactions (other than options)

Β 

Β Class of relevant security

Β Product description

e.g. CFD

Β Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Β Number of reference securities

Β Price per unit

Β 1p ordinary

Β CFD

Β LONG

Β 176

Β 0.4495 GBP

Β 1p ordinary

Β CFD

Β LONG

Β 143

Β 0.4695 GBP

Β 1p ordinary

Β CFD

Β LONG

Β 11

Β 0.4709 GBP

Β 1p ordinary

Β CFD

Β SHORT

Β 16,268

Β 0.4599 GBP

Β 

Β 

(c) Options transactions in respect of existing securities

Β 

(i) Writing, selling, purchasing or varying

Β 

Β Class of relevant security

Β Product description e.g. call option

Β Writing, purchasing, selling, varying etc.

Β Number of securities to which option relates

Β Exercise price per unit

Β Type e.g. American, European etc.

Β Expiry date

Β Option money paid/ received per unit

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β 

(ii) Exercising

Β 

Β Class of relevant security

Β Product description e.g. call option

Β Number of securities

Β Exercise price per unit

Β N/A

Β N/A

Β N/A

Β N/A

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Β Class of relevant security

Β Nature of dealing e.g. subscription, conversion

Β Details

Β Price per unit (if applicable)

Β N/A

Β N/A

Β N/A

Β N/A

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

Β 

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

Β 

Β 

Date of disclosure:

02 JANUARY 2015

Contact name:

Craig Horsley

Telephone number:

+44(141) 245 7736

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FEREAEFAEEXSEFF
Date   Source Headline
31st Jul 201510:39 amRNSCorporate update
27th Jul 20157:00 amRNSUpdate on General Meeting
21st Jul 20154:31 pmRNSUpdate on Upcoming General Meeting
15th Jul 20157:33 amRNSOperational and financial update
15th Jul 20157:30 amRNSSuspension - Afren PLC
8th Jul 20157:00 amRNSPublication of Supplementary Prospectus
1st Jul 20154:54 pmRNSDirector Declaration
25th Jun 20153:31 pmRNSResult of AGM
25th Jun 201511:00 amRNSAGM Statement
25th Jun 20157:00 amRNSBoard changes
22nd Jun 20157:00 amRNSLaunch of shareholder information microsite
19th Jun 20156:26 pmRNSProposed Debt Restructuring and Refinancing
12th Jun 20154:06 pmRNSExecutive Director Resignation / COO Appointment
10th Jun 20157:00 amRNSInterest payment due on 2020 Notes
29th May 20157:00 amRNSInterim Management Statement
29th May 20157:00 amRNSFinal Amount of the New Senior Notes
28th May 201510:58 amRNSNotification of Major Interest in Shares
18th May 20157:00 amRNSResignation of Non-Executive Directors
11th May 20157:00 amRNSInterest payment due on 2019 Notes
30th Apr 20154:37 pmRNSAnnual Financial Report
30th Apr 20154:34 pmRNSCompletion of interim funding
30th Apr 20154:31 pmRNS2014 Full Year Results
9th Apr 20157:00 amRNSInterest payment due on 2019 Notes
8th Apr 201510:34 amRNSResponse to AMNI's allegations regarding Okoro
7th Apr 201511:40 amRNSResponse to reports regarding CEO
1st Apr 20152:08 pmRNSUpdate on interim funding
30th Mar 20154:35 pmRNSPrice Monitoring Extension
23rd Mar 20157:00 amRNSUpdate on discussions with bondholders
20th Mar 20154:40 pmRNSSecond Price Monitoring Extn
20th Mar 20154:35 pmRNSPrice Monitoring Extension
16th Mar 20154:40 pmRNSSecond Price Monitoring Extn
16th Mar 20154:35 pmRNSPrice Monitoring Extension
13th Mar 20157:00 amRNSTrading statement and operations update
4th Mar 20157:00 amRNSUpdate on the Review of Afren's Capital Structure
2nd Mar 20157:00 amRNSUpdate on the Review of Afren's Capital Structure
17th Feb 20152:27 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
17th Feb 20152:22 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
16th Feb 20155:44 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
16th Feb 201511:30 amRNSForm 8.5 (EPT/RI)
16th Feb 201511:07 amRNSForm 8.5 (EPT/RI) - Afren Plc
16th Feb 201511:06 amRNSForm 8.5 (EPT/RI) - Afren Plc
16th Feb 201511:01 amPRNForm 8.3 - Afren Plc
16th Feb 201510:46 amRNSForm 8.5 (EPT/RI)
13th Feb 20154:35 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
13th Feb 20154:22 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
13th Feb 20154:01 pmRNSOffer Talks Terminated
13th Feb 20152:49 pmBUSForm 8.3 - AFREN PLC
13th Feb 20152:17 pmRNSForm 8.3 - [Afren PLC]
13th Feb 20151:56 pmRNSOffer Talks Terminated
13th Feb 20151:43 pmRNSForm 8.3 - Afren PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.